Stock search

Ticker or company name

Compare stocks

Market: US

  • RMDResMed

Add stock

Ticker or company

Summary

RMD
ResMed
$238,19Down −0,56%
Year: Down −5%
83/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckRMD6 ✓ 3 — 0 ✕
P/E vs its history21,3
P/E vs industry21,3
Forward P/E18,4
Revenue growth, YoY+9,0%
EPS growth, YoY+12,4%
Net margin27,8%
Net debt / EBITDA−0,4
Free cash flow$1,61 bn
Share count over a year−2,4%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterRMDTTMIndustry medianTTM
P/E TTM ↓21,325,1
Forward P/E ↓18,416,2
PEG ↓1,82,2
P/S TTM ↓5,92,2
EV/EBITDA ↓16,717,3
P/FCF ↓21,419,5

Price, %

  • RMDn/a

Returns

Best WorstNo mark — in between

PeriodRMD
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

RMD
Share of “buy”52%
Beat the forecast4 of 4
Average “surprise”+3,1%
Insiders over 12 monthssales $20,2 m

Details are on each stock page.